US2429899A - Aluminum salts of bile acids - Google Patents

Aluminum salts of bile acids Download PDF

Info

Publication number
US2429899A
US2429899A US639432A US63943246A US2429899A US 2429899 A US2429899 A US 2429899A US 639432 A US639432 A US 639432A US 63943246 A US63943246 A US 63943246A US 2429899 A US2429899 A US 2429899A
Authority
US
United States
Prior art keywords
aluminum
bile
salt
salts
bile acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US639432A
Inventor
Clarence W Sondern
Richard H Herbine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
White Laboratories Inc
Original Assignee
White Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by White Laboratories Inc filed Critical White Laboratories Inc
Priority to US639432A priority Critical patent/US2429899A/en
Application granted granted Critical
Publication of US2429899A publication Critical patent/US2429899A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/06Aluminium compounds
    • C07F5/069Aluminium compounds without C-aluminium linkages

Definitions

  • This invention relates to certain salts of hydroxycholanic acid, particularly to an aluminum salt thereof and to a process for obtaining such salt in a form useful as a therapeutic; agent.
  • Bile as it is secreted from the gall bladder, contains certain bile salts which are essential to fat metabolism. Chemically, these bile salts comprise the taurine and glycine conjugates of certain hydroxycholanic acids, particularly cholic, desoxycholic and lithocholic acids, which acids are frequently referred to collectively as bile acids. Bile salts aid in the absorption of fats and various fat-soluble vitamins in body metabolism. When the body is deficient in such naturally occurring bile salts, it is common practice to administer certain metal salts of the bile acids in an attempt to procure the same effect as is caused by the naturally occurring substances.
  • the strontium, iron, silver, and sodium salts are examples of the metal salts of the bile acids which have been used to some extent. These salts have proven useful in the treatment of obstructive jaundice, in which malady both digestion and absorption of fatty substances are somewhat inhibited, and in the treatment of certain other ailments. ,However, these metal salts must often be administered in minimal dosages, which are sometimes even below an effective level, since they are relatively toxic. Many of these salts are soluble in weak acids and become active in the stomach, where they are absorbed and released into the blood stream causing a fall in blood pressure and certain other toxic symptoms. Also, the administration of previously known metal salts of the bile acids frequently leads to The need for an easily produced and effective salt of the bile acids which is not subject to the above disadvantages i evident.
  • a further object of the invention is to provide a bile acid salt having a lower degree of toxicity than heretofore known metal salts of the bile acids.
  • An additional object of the invention is toprovide an aluminum compound of a bile acid which may be administered orally in effective doses, and which exhibits its maximum physiological activity in the alkaline regions of the intestinal tract.
  • Another object of this invention is to provide aluminum cholate.
  • An additional object of this invention is to pro Application January 5, 1946, Serial No. 639,432
  • Vide an aluminum bile acid salt in a therapeutically useful form Vide an aluminum bile acid salt in a therapeutically useful form.
  • an aluminum compound of the bile acids herein referred to as an aluminum bile acid salt, and determined certain characteristic properties whereby, it may be identified.
  • the new salt is substantially insoluble in dilute acids present in the stomach and is, consequently, .well tolerated when administered orally. It is, however, soluble in dilute alkalies and decomposes in th intestinal tract to form a water-soluble bile salt which promotes complete and rapid absorption of fatty material and is otherwise valuable therapeutically.
  • Aluminum hydroxide formed simultaneously in the intestine with the soluble bile salt, counteracts the cathartic action and diarrhea generally caused by other metal salts of the bile acids and permits effective amounts of the aluminum bile acid salt to be administered safely.
  • the aluminum salt with which the present invention is concerned is herein referred to as an aluminum bile acid salt and may be prepared readily, as hereinafter described by the reaction of the sodium salt of'a pure bile acid with an aluminum salt, it is understood that the term applies as well to the aluminum salt obtained from the mixture of hydroxycholanic acids usually referred to as bile acids.
  • the new aluminum bile acid salt can be readily prepared by the interaction in aqueous solution of a soluble bile acid salt, preferably an alkalimetal salt, and a water-soluble aluminum salt, such as aluminum chloride, aluminum sulfate, aluminum nitrate, or aluminum acetate. Inorganic aluminum salts are preferably used. When aqueous solutions of water-soluble aluminum salts and of water-soluble bile acid salts aremixed, an aluminum bile acid salt is precipitated. This water-insoluble salt is recovered by filtration and may be washed or dried. Yields in excess of per cent of the theoretical amount, based on the bile acid used, can be obtained.
  • a soluble bile acid salt preferably an alkalimetal salt
  • a water-soluble aluminum salt such as aluminum chloride, aluminum sulfate, aluminum nitrate, or aluminum acetate.
  • Inorganic aluminum salts are preferably used.
  • reaction mixture more than a small excess of free alkali should be present in the reaction mixture.
  • Mixing of the solutions may be accomplished at ordinary room temperature, or at temperatures somewhat higher or lower.
  • the mixture is stirred for a short time to facilitate completion of the reaction and the precipitated aluminum bile acid salt then recovered by filtering, washing with water and drying.
  • Aluminum bile acid salts are white, odorless,
  • Example 1 One hundred twenty-five grams of cholic acid was dissolved in a solution of 12.5 grams of sodium hydroxide (97 per cent) in 500 milliliters of distilled water. This mixture was heated to about 85 to facilitate solution of the cholic acid. The resulting solution of sodium cholate was cooled to room temperature and filtered to remove a Twentyfive and four-tenths grams of aluminum chloride (AlClafiHzO) was then dissolved in about 3.0 liters of distilled water. The sodium cholate solution was added drop-wise tothe aluminum chloride solution over a period of about thirty minutes, the mixing being effected at room temperature. The mixture was agitated during the addition and for about one hour thereafter.
  • AlClafiHzO aluminum chloride
  • amorphous, white powder suitable for therapeutic use. It contained 4.76 per cent of aluminum (calculated as A1203) and partially melted When heate t 2 0 o 5 C,
  • Example 2 A solution of sodium cholate was prepared by dissolving 10.1 grams of sodium hydoxide (97 per cent) in 400 milliliters of distilled water, heating the mixture to C. and stirring into the hot solution 100 grams of cholic acid. The soluwas cooled and filtered. The pH of the sodium cholate solution was 11.5.
  • An aluminum chloride solution was prepared by dissolving 20.32 grams of aluminum chloride (A1C'13.6H2Q) in 400 milliliters of distilled Water. This solution had a pH of 2.9.
  • the sodium cholate and aluminum chloride solutions were added simultaneously and over a period of about forty-five minutes to two liters of distilled water at room temperature. The mixture was agitated during the addition and for two hours after the addition was complete. After standing for four days, the mixture was filtered with suction. The filtrate had a .pH of 3.69. The aluminum cholate was washed on. the filter until the washings no longer gave a precipitate of silver chloride with silver nitrate test solution. The aluminum cholate was then dried at C. The dry product consisted of 93.5 grams of a white, tasteless, odorless, amorphous powder. The aluminum content, as determined by washing a small sample, was 4.55 per cent, calculated as A1203. The substance softened and partially melted at 225 to 230 -C'. It had an apparent solubility in ether of 0.242 gram per hundred CLARENCE W. SONDERN. RICHARD H. .I-IERBINE.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

an extensive diarrhea.
Patented Oct. 28, 1947 ALUMINUM SALTS F BILE ACIDS Clarence W. Sondern, Mendham, and Richard H. Herbine, Montville, N. J., assignors to White Laboratories, Incorporated, Newark, N. J., a corporation of New Jersey No Drawing.
2 Claims.
This invention relates to certain salts of hydroxycholanic acid, particularly to an aluminum salt thereof and to a process for obtaining such salt in a form useful as a therapeutic; agent.
Bile, as it is secreted from the gall bladder, contains certain bile salts which are essential to fat metabolism. Chemically, these bile salts comprise the taurine and glycine conjugates of certain hydroxycholanic acids, particularly cholic, desoxycholic and lithocholic acids, which acids are frequently referred to collectively as bile acids. Bile salts aid in the absorption of fats and various fat-soluble vitamins in body metabolism. When the body is deficient in such naturally occurring bile salts, it is common practice to administer certain metal salts of the bile acids in an attempt to procure the same effect as is caused by the naturally occurring substances.
Among the metal salts of the bile acids which have been used to some extent may be mentioned the strontium, iron, silver, and sodium salts. These salts have proven useful in the treatment of obstructive jaundice, in which malady both digestion and absorption of fatty substances are somewhat inhibited, and in the treatment of certain other ailments. ,However, these metal salts must often be administered in minimal dosages, which are sometimes even below an effective level, since they are relatively toxic. Many of these salts are soluble in weak acids and become active in the stomach, where they are absorbed and released into the blood stream causing a fall in blood pressure and certain other toxic symptoms. Also, the administration of previously known metal salts of the bile acids frequently leads to The need for an easily produced and effective salt of the bile acids which is not subject to the above disadvantages i evident.
It is, therefore, a principal object of this invention to provide a bile acid salt which is of therapeutic value and which is not subject to the disadvantages set forth above.
A further object of the invention is to provide a bile acid salt having a lower degree of toxicity than heretofore known metal salts of the bile acids.
An additional object of the invention is toprovide an aluminum compound of a bile acid which may be administered orally in effective doses, and which exhibits its maximum physiological activity in the alkaline regions of the intestinal tract.
Another object of this invention is to provide aluminum cholate.
An additional object of this invention is to pro Application January 5, 1946, Serial No. 639,432
Vide an aluminum bile acid salt in a therapeutically useful form.
We have prepared an aluminum compound of the bile acids, herein referred to as an aluminum bile acid salt, and determined certain characteristic properties whereby, it may be identified. The new salt is substantially insoluble in dilute acids present in the stomach and is, consequently, .well tolerated when administered orally. It is, however, soluble in dilute alkalies and decomposes in th intestinal tract to form a water-soluble bile salt which promotes complete and rapid absorption of fatty material and is otherwise valuable therapeutically. Aluminum hydroxide, formed simultaneously in the intestine with the soluble bile salt, counteracts the cathartic action and diarrhea generally caused by other metal salts of the bile acids and permits effective amounts of the aluminum bile acid salt to be administered safely.
Although the aluminum salt with which the present invention is concerned is herein referred to as an aluminum bile acid salt and may be prepared readily, as hereinafter described by the reaction of the sodium salt of'a pure bile acid with an aluminum salt, it is understood that the term applies as well to the aluminum salt obtained from the mixture of hydroxycholanic acids usually referred to as bile acids.
The new aluminum bile acid salt can be readily prepared by the interaction in aqueous solution of a soluble bile acid salt, preferably an alkalimetal salt, and a water-soluble aluminum salt, such as aluminum chloride, aluminum sulfate, aluminum nitrate, or aluminum acetate. Inorganic aluminum salts are preferably used. When aqueous solutions of water-soluble aluminum salts and of water-soluble bile acid salts aremixed, an aluminum bile acid salt is precipitated. This water-insoluble salt is recovered by filtration and may be washed or dried. Yields in excess of per cent of the theoretical amount, based on the bile acid used, can be obtained.
The preparation of the new aluminum bile acid salt. Although substantially chemically equivalent quantities of the ingredients are preferably used in the interest-of economy, considerable deviation therefrom may occur without causing undue difficulty. For best results, however, not
'small amount of insoluble impurities.
more than a small excess of free alkali should be present in the reaction mixture. Mixing of the solutions may be accomplished at ordinary room temperature, or at temperatures somewhat higher or lower. Following the mlXing of the solutions of reagents, the mixture is stirred for a short time to facilitate completion of the reaction and the precipitated aluminum bile acid salt then recovered by filtering, washing with water and drying.
Aluminum bile acid salts are white, odorless,
tasteless, amorphous substances which are only slightly soluble in alcohol, ether, water or 0.1 N hydrochloric acid. They are decomposedby-dilute alkalies with the formation of aluminum hydroxide and a. salt of the bile acid. Representative samples soften and at least partially melt unsharply at fro-m 225 to 255 C. The substances contain from about 4.5 to about 5.0 per cent of aluminum (calculated as A1203) as determined by ignition, and thus appear to contain somewhat more aluminum than might be ex-- pec'ted by considering the theoretical formulae of the salts. This may be due to the presence of a certain amount of aluminum hydroxide formed during the precipitation of the aluminum bile acid salt or it may be that a certain degree of combination of aluminum with one or more hydroxyl groups of the bile acid occurs.
The following examples illustrate the preparation of aluminum bile acid salts, but are not to be construed as limiting.
Example 1 One hundred twenty-five grams of cholic acid was dissolved in a solution of 12.5 grams of sodium hydroxide (97 per cent) in 500 milliliters of distilled water. This mixture was heated to about 85 to facilitate solution of the cholic acid. The resulting solution of sodium cholate was cooled to room temperature and filtered to remove a Twentyfive and four-tenths grams of aluminum chloride (AlClafiHzO) was then dissolved in about 3.0 liters of distilled water. The sodium cholate solution was added drop-wise tothe aluminum chloride solution over a period of about thirty minutes, the mixing being effected at room temperature. The mixture was agitated during the addition and for about one hour thereafter. The mixture was then filtered with suction, the precipitate washed free from chlorides with hot distilled water, and dried to constant weight at about 105 centigrade. One hundred sixteen and sixtenths grams of dry product was obtained. The product thus isolated was a tasteless, odorless,
amorphous, white powder, suitable for therapeutic use. It contained 4.76 per cent of aluminum (calculated as A1203) and partially melted When heate t 2 0 o 5 C,
Example 2 A solution of sodium cholate was prepared by dissolving 10.1 grams of sodium hydoxide (97 per cent) in 400 milliliters of distilled water, heating the mixture to C. and stirring into the hot solution 100 grams of cholic acid. The soluwas cooled and filtered. The pH of the sodium cholate solution was 11.5.
An aluminum chloride solution was prepared by dissolving 20.32 grams of aluminum chloride (A1C'13.6H2Q) in 400 milliliters of distilled Water. This solution had a pH of 2.9.
The sodium cholate and aluminum chloride solutions were added simultaneously and over a period of about forty-five minutes to two liters of distilled water at room temperature. The mixture was agitated during the addition and for two hours after the addition was complete. After standing for four days, the mixture was filtered with suction. The filtrate had a .pH of 3.69. The aluminum cholate was washed on. the filter until the washings no longer gave a precipitate of silver chloride with silver nitrate test solution. The aluminum cholate was then dried at C. The dry product consisted of 93.5 grams of a white, tasteless, odorless, amorphous powder. The aluminum content, as determined by washing a small sample, was 4.55 per cent, calculated as A1203. The substance softened and partially melted at 225 to 230 -C'. It had an apparent solubility in ether of 0.242 gram per hundred CLARENCE W. SONDERN. RICHARD H. .I-IERBINE.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 2,034,333 Doubilet Mar. 1'7, 1936 2,144,855 Rutherford Jan .24, 1939 2,306,826 Mendelsohn Dec. 29, 1942 OTHER REFERENCES Fi'eser, Chemistry of Natural Products Related to Phenanthrene, 1936, p. 126.
US639432A 1946-01-05 1946-01-05 Aluminum salts of bile acids Expired - Lifetime US2429899A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US639432A US2429899A (en) 1946-01-05 1946-01-05 Aluminum salts of bile acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US639432A US2429899A (en) 1946-01-05 1946-01-05 Aluminum salts of bile acids

Publications (1)

Publication Number Publication Date
US2429899A true US2429899A (en) 1947-10-28

Family

ID=24564053

Family Applications (1)

Application Number Title Priority Date Filing Date
US639432A Expired - Lifetime US2429899A (en) 1946-01-05 1946-01-05 Aluminum salts of bile acids

Country Status (1)

Country Link
US (1) US2429899A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944578A (en) * 1973-11-23 1976-03-16 The United States Of America As Represented By The Secretary Of The Navy Organic superconductors with high transition temperatures and high critical magnetic fields
EP0092073A1 (en) * 1982-04-15 1983-10-26 SCHWARZ ITALIA S.p.A. Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2034333A (en) * 1935-08-02 1936-03-17 Lilly Co Eli Iron bile salt and process of making it
US2144855A (en) * 1936-09-14 1939-01-24 Standard Oil Co Method of preparing compounded lubricating oil
US2306826A (en) * 1941-10-13 1942-12-29 Mendelsohn Majer Method for the manufacture of aluminum acetate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2034333A (en) * 1935-08-02 1936-03-17 Lilly Co Eli Iron bile salt and process of making it
US2144855A (en) * 1936-09-14 1939-01-24 Standard Oil Co Method of preparing compounded lubricating oil
US2306826A (en) * 1941-10-13 1942-12-29 Mendelsohn Majer Method for the manufacture of aluminum acetate

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944578A (en) * 1973-11-23 1976-03-16 The United States Of America As Represented By The Secretary Of The Navy Organic superconductors with high transition temperatures and high critical magnetic fields
EP0092073A1 (en) * 1982-04-15 1983-10-26 SCHWARZ ITALIA S.p.A. Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle

Similar Documents

Publication Publication Date Title
US1950100A (en) Chondroitin compounds and their preparation
US2429899A (en) Aluminum salts of bile acids
US3361769A (en) Bi-metallic salts of gluconic, glucuronic, or galacturonic acid
US3734734A (en) Deproteinizing protein-containing solutions
US3306819A (en) Derivative of pectin, its process of preparation and its method of use
US3952096A (en) Mixture of calcium carbonate and calcium-α-p-chlorophenoxyisobutyrate as an antihyperlipemic agent
US2230616A (en) Bismuth nicotinate
US3000874A (en) Sulfate salt of erythromycin monoester
US2481804A (en) Penicillin-pectin composition and method of manufacture
US1540883A (en) Vitamine preparation
US3211617A (en) Heparine derivatives and process for preparation and utilization
US1218472A (en) Growth-controlling substance derived from the anterior lobe of the pituitary gland and process for producing the same.
US2434625A (en) Preparation of alkali metal ascorbates
US3455894A (en) Process of preparing high potency iodinated protein which comprises reacting said protein with ba(oh)2 at a temperature of at least 110 c.
DE2259151A1 (en) PROCESS FOR MANUFACTURING ANTIBIOTIC DERIVATE
DE1543733C3 (en) Aluminum bis-alpha- (p-chlorophenoxy) isobutyrate and brightening agents containing this compound as an active ingredient
US3148122A (en) Water-insoluble whole pollen complex and method of making same
US2260870A (en) Medicinal preparation
US1555016A (en) Remedy and process of making the same
US2252822A (en) Sulphanilamide solution
US2686800A (en) Basic aluminum para-amino salicylate and method of making
US2194677A (en) Silver animal mucin and process for producing same
US2307189A (en) X-ray contrast composition
US1939166A (en) Treatment of intestinal tract
US4029771A (en) Composition for the treatment of bacterial-intestinal infections